Carle Cancer Center is the premier cancer treatment and support center in east central Illinois, offering more resources to help patients in the fight against cancer. With the area's largest and most specialized team of fellowship trained oncologists, surgeons and staff, patients get in for diagnosis and start treatment as soon as possible. Our team offers the latest technology and highly specialized multidisciplinary clinics for certain cancers, including breast, prostate, gynecologic, and head and neck. But we don't just treat a disease – we care for the whole patient, offering support groups, genetic and nutrition counseling, nurse navigator services and more.
Our experts in oncology, breast imaging, reconstructive surgery, genetics, research and support services, give you the tools you need in the fight against breast cancer.
With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment for patients with gastrointestinal cancer.
Carle gynecologic oncology team serves women who have or are suspected of having ovarian, cervical, endometrial, and vulvar cancers.
The Carle Cancer Center focuses on aggressive and effective treatment, helping to instill hope in patients undergoing what is often an unknown journey.
With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment for patients with lung cancer.
With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment for patients with lymphoma and leukemia.
Experts at Carle Cancer Center along with Dermatology and Plastic Surgery experts develop and individualized plan for patients with skin cancer.
Our urologic cancer practice is based on a multi-specialty approach that combines clinical expertise from urology and radiation oncology.
Have a patient referral? Refer a patient now.
Involved in national research for more than 30 years, Carle Cancer Center offers its patients access to innovative ways to fight cancer through clinical trials. Clinical trials offer new insight into how to combat a disease like cancer and demonstrate new ways of preventing, treating, or possibly curing cancer.
Carle Cancer Center provides access to clinical trials for several types of cancer including but not limited to breast, lung, colon, melanoma, prostate, and ovarian cancer. We are also actively involved in national prevention clinical trials per cancer type. In addition, we offer symptom management program to address the quality of life of cancer patients.
This phase II trial studies the side effects and best dose of niraparib, and to see how well it works in combination with standard of care radiation therapy and hormonal therapy (androgen deprivation therapy) in treating patients with prostate cancer that has a high chance of coming back (high risk). Niraparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Adding niraparib to the usual treatments of radiation therapy and hormonal therapy may lower the chance of prostate cancer growing or returning.
This phase III trial studies how well adding apalutamide, abiraterone acetate, and prednisone to the usual hormone therapy and radiation therapy works compared to the usual hormone therapy and radiation therapy in treating patients with node-positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or slow the growth of prostate cancer cell growth by blocking the androgens. Abiraterone acetate blocks some of the enzymes needed for androgen production and may cause the death of prostate cancer cells that need androgens to grow. Prednisone may help abiraterone acetate work better by making tumor cells more sensitive to the drug. Adding apalutamide and abiraterone acetate with prednisone to the usual usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading or extend time without disease spreading compared to the usual approach.
This randomized phase III trial studies radiation therapy and cisplatin with triapine to see how well they work compared to the standard radiation therapy and cisplatin alone in treating patients with newly diagnosed stage IB2, II, or IIIB-IVA cervical cancer or stage II-IVA vaginal cancer. Radiation therapy uses high energy protons to kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Triapine may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether radiation therapy and cisplatin are more effective with triapine in treating cervical or vaginal cancer.
With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.
Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for cancer patients and their loved ones. With your support, we’ll continue to work to eliminate cancer through excellence in diagnosis, treatment, research and education.
Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.